Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 2/2024

Edition 1/2024

Edition 4/2023

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): A multicenter, open-label randomized controlled trial

Lancet Gastroenterol Hepatol. 2024 [ahead of print]

Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected celiac disease without IgA deficiency (Bi.A.CeD): A multicenter, prospective cohort study

Lancet Gastroenterol Hepatol. 2023;8(11):1005–14

Persistent villous atrophy predicts development of complications and mortality in adult patients with celiac disease: A multicenter longitudinal cohort study and development of a score to identify high-risk patients

Gut. 2023;72(11):2095–102

Psychological processes, not physiological parameters, are most important contributors to symptom severity in patients with refractory heartburn/regurgitation symptoms

Gastroenterology. 2023;165(4):848–60

Bismuth quadruple three-in-one single capsule 3 times a day increases effectiveness compared with the usual 4 times a day schedule: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Gut. 2023;72(11):2031–7

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic esophagitis (LIBERTY EoE TREET study): A multicenter, double-blind, randomized, placebo-controlled, phase 3 trial

Lancet Gastroenterol Hepatol. 2023;8(11):990–1004

Epidemiologic burden and projections for eosinophilic esophagitis-associated emergency department visits in the United States: 2009–2030

Clin Gastroenterol Hepatol. 2023;21(12):3041–50.e3

Mepolizumab for treatment of adolescents and adults with eosinophilic esophagitis: A multicenter, randomized, double-blind, placebo-controlled clinical trial

Gut. 2023;72(10):1828–37

Comparison of drugs for active eosinophilic esophagitis: Systematic review and network meta-analysis

Gut. 2023;72(11):2019–30